The Meeting Worth Lobbying For: A “PRG” For Disease-Specific Review; NCI Plans Six.
Dana-Farber Picks Rosenthal To Direct New Center For Integrated Therapies.
Weinstein Receives Award; LRFA Honors Vincent Devita.
New Office For Protection Of Research Subjects Formed.
Marijuana Ingredient Promotes Tumor Growth, Study Finds.
Cvitkovic Responds To Story On March ODAC Meeting.
Trending Stories
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit - Did Vinay Prasad need to mention the Nazis to make a point on the U.S. pandemic response?
- NIH cuts threaten U.S. edge in biomedical research: “We are giving China the opportunity of a lifetime”
Cancer research also took center stage at Senate appropriations hearing - The White House “skinny budget” document cuts NIH by nearly 40%
The cuts are consistent with the previously leaked “passback” document